These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 15614311)

  • 1. Duloxetine Treatment of Stress Urinary Incontinence in Women Does Not Induce Mania or Hypomania.
    Viktrup L; Perahia DG; Tylee A
    Prim Care Companion J Clin Psychiatry; 2004; 6(6):239-243. PubMed ID: 15614311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is treatment-associated hypomania rare with duloxetine: secondary analysis of controlled trials in non-bipolar depression.
    Dunner DL; D'Souza DN; Kajdasz DK; Detke MJ; Russell JM
    J Affect Disord; 2005 Jul; 87(1):115-9. PubMed ID: 15967235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary Side Effects of Duloxetine in the Treatment of Depression and Stress Urinary Incontinence.
    Viktrup L; Pangallo BA; Detke MJ; Zinner NR
    Prim Care Companion J Clin Psychiatry; 2004; 6(2):65-73. PubMed ID: 15254599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bipolar II disorder : epidemiology, diagnosis and management.
    Benazzi F
    CNS Drugs; 2007; 21(9):727-40. PubMed ID: 17696573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
    Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of adjunctive second-generation antidepressant therapy with a mood stabiliser or an atypical antipsychotic in acute bipolar depression: a systematic review and meta-analysis of randomised placebo-controlled trials.
    McGirr A; Vöhringer PA; Ghaemi SN; Lam RW; Yatham LN
    Lancet Psychiatry; 2016 Dec; 3(12):1138-1146. PubMed ID: 28100425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ECNP consensus meeting. Bipolar depression. Nice, March 2007.
    Goodwin GM; Anderson I; Arango C; Bowden CL; Henry C; Mitchell PB; Nolen WA; Vieta E; Wittchen HU
    Eur Neuropsychopharmacol; 2008 Jul; 18(7):535-49. PubMed ID: 18501566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Duloxetine 60 mg once-daily in the treatment of painful physical symptoms in patients with major depressive disorder.
    Brannan SK; Mallinckrodt CH; Brown EB; Wohlreich MM; Watkin JG; Schatzberg AF
    J Psychiatr Res; 2005 Jan; 39(1):43-53. PubMed ID: 15504423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized controlled trial of duloxetine versus placebo in the treatment of nonmajor chronic depression.
    Hellerstein DJ; Stewart JW; McGrath PJ; Deliyannides DA; Batchelder ST; Black SR; Withers A; O'Shea D; Chen Y
    J Clin Psychiatry; 2012 Jul; 73(7):984-91. PubMed ID: 22901348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dosage-related nature of escitalopram treatment-emergent mania/hypomania: a case series.
    Yamaguchi Y; Kimoto S; Nagahama T; Kishimoto T
    Neuropsychiatr Dis Treat; 2018; 14():2099-2104. PubMed ID: 30147322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Classifying mood disorders by age-at-onset instead of polarity.
    Benazzi F
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):86-93. PubMed ID: 18992784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duloxetine in the treatment of major psychiatric and neuropathic disorders.
    Müller N; Schennach R; Riedel M; Möller HJ
    Expert Rev Neurother; 2008 Apr; 8(4):527-36. PubMed ID: 18416656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of efficacy of duloxetine in stress urinary incontinence in women.
    Deepak P; Kumar TN; Sen TK
    Indian J Pharmacol; 2011 Apr; 43(2):176-9. PubMed ID: 21572653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mixed urinary incontinence symptoms: urodynamic findings, incontinence severity, and treatment response.
    Bump RC; Norton PA; Zinner NR; Yalcin I;
    Obstet Gynecol; 2003 Jul; 102(1):76-83. PubMed ID: 12850610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder.
    Arnold LM; Lu Y; Crofford LJ; Wohlreich M; Detke MJ; Iyengar S; Goldstein DJ
    Arthritis Rheum; 2004 Sep; 50(9):2974-84. PubMed ID: 15457467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Duloxetine compared with placebo for the treatment of women with mixed urinary incontinence.
    Bent AE; Gousse AE; Hendrix SL; Klutke CG; Monga AK; Yuen CK; Muram D; Yalcin I; Bump RC
    Neurourol Urodyn; 2008; 27(3):212-21. PubMed ID: 17580357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Duloxetine compared with placebo for treating women with symptoms of overactive bladder.
    Steers WD; Herschorn S; Kreder KJ; Moore K; Strohbehn K; Yalcin I; Bump RC;
    BJU Int; 2007 Aug; 100(2):337-45. PubMed ID: 17511767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duloxetine for management of stress urinary incontinence.
    Guay DR
    Am J Geriatr Pharmacother; 2005 Mar; 3(1):25-38. PubMed ID: 16089245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Duloxetine in the treatment of stress urinary incontinence.
    Michel MC; Oelke M
    Womens Health (Lond); 2005 Nov; 1(3):345-58. PubMed ID: 19803876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.